Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden · Delayed Price · Currency is SEK 1.140
-0.010 (-0.87%)
At close: Mar 2, 2026
STO:NEWBRY Market Cap
STO:NEWBRY has a market cap or net worth of 34.65 million as of March 2, 2026. Its market cap has decreased by -59.87% in one year.
Market Cap
34.65M
Enterprise Value
26.73M
Revenue
36.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.14
Market Cap Chart
Since February 4, 2022, STO:NEWBRY's market cap has decreased from 245.97M to 34.65M, a decrease of -85.91%. That is a compound annual growth rate of -38.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 34.65M | -0.87% |
| Dec 30, 2025 | 34.96M | -59.06% |
| Dec 30, 2024 | 85.39M | 42.48% |
| Dec 29, 2023 | 59.93M | -56.08% |
| Dec 30, 2022 | 136.45M | -44.52% |
| Feb 4, 2022 | 245.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EQL Pharma AB | 1.71B |
| Orexo AB | 990.58M |
| Cinclus Pharma Holding AB | 811.62M |
| Nanexa AB | 655.87M |
| Dicot Pharma AB | 599.79M |
| Moberg Pharma AB | 486.46M |
| Enzymatica AB | 475.76M |
| Klaria Pharma Holding AB (publ.) | 201.21M |